Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/NovellusDX

NovellusDX

Other
Jerusalem, IsraelFeb 2018
Healthtech

NovellusDX raised €4.8M in a funding round in Feb 2018. The company is based in Jerusalem, Israel. Investors in the round: Bio Capital Impact Fund, Helsinn Investment Fund S.A. SICAR, Windham Venture Partners. Data as of Nov 2026.

← NovellusDX
Amount raised
€4.8M
€4,816,569
Native amount
6,000,000 USD
Stage
Other
Investors
3

Provenance & confidence

High confidence
Amount
6,000,000 USD
ECB-at-date → €4.8M · rate 1.2457 on 2018-01-31
High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

3 named
Bio Capital Impact FundHelsinn Investment Fund S.A. SICARWindham Venture Partners
Date
Feb 2018
Round type
—
Amount (EUR)
€4.8M

Other rounds

same company

This is the company's only recorded round.

Related news